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Exosomes are small membrane vesicles that are secreted
from a variety of cell types into various body fluids including
the blood and urine. These vesicles are thought to play a role
in cell–cell interactions. CD24 is a small but extensively
glycosylated protein linked to the cell surface by means of a
glycosyl-phosphatidylinositol anchor. In this study we found
that CD24 is present in membrane vesicles characterized as
exosomes that were isolated from the urine of normal
individuals. CD24 was expressed by both tubule cells and
podocytes and treatment of the latter with a
cholesterol-extracting agent, but not with a calcium
ionophore, caused the release of CD24-containing exosomes.
Using CD24 as a marker, we found exosomes in the urine of
newborn infants and in the amniotic fluid of pregnant
women with similar findings made in mice. Interestingly,
studies with CD24 knockout mice showed that the exosomes
are released from the fetus but not from the mother;
however, exosome release was similar from both the
knockout and the wild-type mice. This indicates that CD24
is not essential for exosome formation or release but may
be a convenient exosome marker. Our studies suggest
that exosomal secretion from the embryonic kidney
could play a biological role at the fetal–maternal
interphase.
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Exosomes are membrane vesicles with a size of 40–100 nm
that are released from a variety of different cell types
including tumor cells, red blood cells, platelets, lymphocytes,
and dendritic cells.1,2 Exosomes are formed by invagination
and budding from the limiting membrane of late endo-
somes.3 They accumulate in cytosolic multivesicular bodies
from where they are released by fusion with the plasma
membrane.3 The process of vesicle shedding is particularly
active in proliferating cells, such as cancer cells, where the
release can occur continuously.4 Depending on the cellular
origin, exosomes recruit various cellular proteins that can be
different from the plasma membrane including major
histocompatibility complex molecules, tetraspanins, adhesion
molecules, and metalloproteinases.1,2,5 Exosomes have been
found in various body fluids such as blood plasma,6
malignant ascites,7 and urine.8 It has been proposed that
under physiological conditions exosomes could play a role in
cell–cell interactions.9,10 When released from tumor cells,
exosomes can promote invasion and migration.4,11
CD24 is a membrane glycoprotein with unusual lipid-like,
organic-solvent soluble and heat-stable features.12 These
characteristics are due to a small protein (mouse CD24 has
27 amino acids, human CD24 consists of 31 amino acids),
extensive core N- or O-linked glycosylation, and the linkage
to the cell membrane via a glycosyl-phosphatidylinositol
(GPI) anchor.12 In humans, CD24 is expressed by hemato-
poietic subpopulations of B- and T lymphocytes but also on
granulocytes and many carcinomas (for review see Kristian-
sen et al.13). Due to a GPI anchor, CD24 is exclusively
localized in lipid rafts.14 GPI-anchored proteins are highly
enriched in exosomes.2,3,15
Exosomes in human urine have been studied as a novel
diagnostic means for kidney-related diseases.8 By marker
analysis it was shown that exosomes are derived from
different kidney regions.8 Although exosomal analysis in
human urine may offer novel diagnostic insights, a central
question remains unaddressed: why are exosomes present in
urine and what is the biological role of the exosomal
secretion mechanism? Several possibilities could be envi-
saged: (i) exosome secretion from the kidney is important for
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the detoxification of the organism; (ii) the exosome secretion
may be part of a protein and lipid degradation pathway in the
kidney; and (iii) exosome secretion is a primordial mechan-
ism in adults, but plays a role during fetal development when
the kidney of the infant releases exosomes into the amniotic
fluid. The latter hypothesis leads to explicit predictions that
can be tested directly. To do so, we have analyzed exosomes in
the urine using the GPI-linked protein CD24 as a marker. We
find that CD24 is indeed a marker for urinary exosomes and
is present in the urine of men and mice. The exosomes are
likely derived from cells that face the urinary space including
those that express CD24. Importantly, we observed CD24-
positive exosomes already in the urine of newborn and in the
amniotic fluid during pregnancy. These findings suggest that
exosomal secretion from the kidney is indeed an early event
during embryogenesis, continues for lifetime and is preserved
over species barriers.
RESULTS
CD24-containing exosomes in urine of adults
We observed that the urine of healthy individuals contained
significant amounts of CD24 as detected by Western blot
analysis (Figure 1a, left panel). To find out whether CD24 was
in a soluble or membrane-bound form, we subjected urine to
ultracentrifugation. The analysis of depleted supernatant and
pelleted vesicles indicated that the CD24 activity was present
in the 100 000 g pellet (Figure 1a, middle panel) but was not
detected in the cleared supernatant (Figure 1a, right panel).
The analyses were confirmed for n430 individuals and
representative examples are shown in Figure 1b. Some
individuals donated urine samples during the course of the
day but only little variation in the amount of CD24-positive
vesicles were noted. An average of 7.21 mg/ml (range
1.6–13 mg/ml, n¼ 11) of protein was recovered per urine
sample. Of approximately 120 samples analyzed, only o5%
were negative or low for CD24-vesicles content for reasons
presently unknown (data not shown).
We suspected that the pelleted material might represent
membrane vesicles in the form of exosomes. Indeed, vesicles
showed positive reactivity with antibodies to HSP70 (Figure
1c), CD9, and annexin-I (see below). These antigens are
enriched in exosomes.1,2 All samples were positive for the
kidney marker aquaporin-2 that is known to occur in urinary
exosomes (Figure 1c).
Exosomes are released from cells by fusion of multi-
vesicular bodies with the plasma membrane and have an
orientation of cell surface antigens similar to the cell.1–3 To
determine the orientation of antigens, we immobilized
urinary vesicles onto latex beads and carried out fluores-
cence-activated cell sorter (FACS) analysis. Vesicles were
readily stained with antibodies to CD24 (Figure 2a). As
detected by electronmicroscopy, the vesicles were of variable
size ranging predominantly from 20 to 100 nm (Figure 2c).
We carried out sucrose density centrifugation, in combi-
nation with Western blot analysis to further characterize the
released membrane vesicles. Fractions in the middle part of
the gradient (density 1.05–1.15 mg/ml) representing
exosomes were positive for CD24 and annexin-I (Figure 2b).
We concluded that the urinary vesicles containing CD24 had
all characteristics of being exosomes.
Origin of CD24-positive exosomes
Marker analysis in adults has shown earlier that urinary
vesicles are derived from distinct regions of the kidney.8
Using immunohistochemistry on serial sections, we inves-
tigated the expression of CD24 in human kidney in
combination with defined cell subset markers. CD24 expres-
sion was observed in the aquaporin-2-positive collecting duct
(Figure 3a), in calbinin-positive distal tubular cells (Figure
3b), and the Tamm–Horsfall-positive thick ascending limp of
the Henle loop (Figure 3c). To examine whether podocytes
were CD24-positive, we employed two color staining using
monoclonal antibody (mAb) WT1 against a podocyte-
specific nuclear antigen and SWA11 for CD24. As shown in
Figure 3d, double-positive cells, but also CD24-single-
positive cells, were clearly detected in the glomeruli.
We also examined the expression of CD24 in cultured cell
lines derived from the human kidney. We observed CD24
expression by FACS analysis in immortalized human
podocytes (HPCs), the HK-2 human proximal tubular
epithelial cell line, and in human mesangial cells (Figure 3c).
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Figure 1 | Identification of CD24-containing urinary vesicles.
(a) Two representative urine samples were either analyzed after
trichloroacetic acid precipitation (left panel) or after
ultracentrifugation at 100 000 g for 3 h. Pelleted vesicles (middle
panel) or cleared supernatants (right panel) were analyzed by
SDS-polyacrylamide gel electrophoresis and Western blot analysis
using mAb SWA11 to CD24 and enhanced chemiluminescence
detection. (b) A representative panel of CD24 containing urinary
vesicles is shown. Membrane vesicles were obtained after
ultracentrifugation of urine and analyzed by Western blot analysis
using mAb SWA11 to CD24 and enhanced chemiluminescence
detection. F50: female 50 years old; M27: male 27 years old. (c)
Membrane vesicles were analyzed for CD24, aquaporin-2, and
HSP70 by Western blot analysis using respective antibodies.
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These findings suggested that CD24-containing exosomes in
the urine were likely derived from the kidney.
Regulated exosomal secretion in HPCs
We previously reported that the secretion of exosomes is
constitutive but can be significantly enhanced in human
tumor cells by exposure to substances such as the Ca-
ionophore ionomycin, 4-aminophenylmercuric acetate,
methyl-b-cyclodextrin (MCD), or cisplatin.16,17 We treated
differentiated HPC with ionomycin (10 mg/ml), MCD
(10 mg/ml), or cisplatin (1mg/ml) and analyzed the amount
of exosomes released. Only MCD significantly augmented the
release of CD24-containing exosomes (Figure 4). The vesicles
contained the exosomal marker HSP70 but not annexin-I.
These results suggest that the exosomal release can be
regulated in HPC.
CD24 exosomes are present in the urine of newborn and
amniotic fluid
We observed that the presence of CD24-containing exosomes
in urine samples was not restricted to adults but could also be
found in infants. As shown in Figure 5a, the urine of
newborns contained significant amounts of CD24-positive
exosomes that were both positive for aquaporin-2 and
HSP70.
The renal system of the fetus contributes to the
production of amniotic fluid. To analyze whether exosomes
from the fetus were already released early in the pregnancy,
we examined amniotic fluid collected at approximately week
16 of gestation for routine amniocentesis. Indeed, in all
(n¼ 4) amniotic fluids tested, exosomes containing CD24
and CD9 were detected (Figure 5b). To analyze whether the
CD24-positive exosomes were derived from the fetus, we
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Figure 2 | Characterization of urinary vesicles. (a) Exosomes isolated from urine were adsorbed to latex beads and stained for CD24 followed
by phycoerythrin-conjugated goat anti-mouse immunoglobulin G and FACS analysis. The negative control represent beads stained with
the secondary antibody only. The gray curve represents the autofluorescence of unstained beads. (b) Exosomes were subjected to sucrose
density centrifugation and the collected fractions from the gradient were analyzed by Western blot analysis with the indicated antibodies
to CD24 and the exosomal marker protein annexin-I followed by peroxidase-conjugated secondary antibody and enhanced
chemiluminescence detection. The density of the gradient fractions is depicted in the graph below. (c) Electronmicroscopy pictures and
size distribution analysis of urinary vesicles.
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used a refined sucrose gradient capable of separating distinct
exosome subpopulations on the basis of buoyant density (see
Figure 6a). The analysis revealed two populations of
exosomes: a light fraction floating on top of the gradient
(1.08–1.11 mg/ml) contained CD24, the kidney marker aqua-
porin-2; and annexin-I, a more dense fraction (1.11–1.14 mg/ml)
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Figure 3 | Expression of CD24 in adult kidney. Staining was carried out in combination with cell type-specific markers in serial sections.
(a) Analysis of CD24 and aquaporin-2 (collecting duct); (b) CD24 and calbindin (distal tubules); (c) CD24 and Tamm–Horsfall (thick ascending
limp of Henle loop). (d) Analysis of CD24 staining in glomeruli using the podocyte marker WT1 (blue) and SWA11 (red). Note the enlarged
picture (right) marking double-stained cells with arrows. (e) Cultured human tubular cells (HK-2), human mesangial cells, or differentiated
HPC were stained with mAb to CD24 followed by phycoerythrin-conjugated goat anti-mouse immunoglobulin G and FACS analysis.
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Figure 4 | Regulation of exosome secretion. Cultured HPC
(differentiated) were treated with ionomycin (1 mM), MCD (10 mM),
or cisplatin (15 mM) for 2 h. Secreted membrane vesicles were
harvested and cells were lysed in lysis buffer. Lysates and isolated
vesicles were analyzed by SDS-polyacrylamide gel electrophoresis
followed by Western blot analysis with the indicated antibodies to
CD24 and the exosomal marker proteins, HSP70 and annexin-I. Note
the low level of constitutive vesicle secretion that is augmented by
MCD.
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Figure 5 | CD24-containing exosomes in the urine from newborn
and amniotic fluid. (a) Exosomes isolated from the urine of newborn
were analyzed for CD24, aquaporin-2, and HSP70 by Western blot
analysis. Two examples from n¼ 5 samples with similar results are
shown. (b) Exosomes isolated from the amniotic fluid of women
undergoing amnioncentesis were analyzed for CD24 and CD9 by
Western blot analysis. Two examples from n¼ 4 with similar results
are shown.
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containing only HSP70 and annexin-I (Figure 6b). These
results suggested that the CD24-positive exosomes were likely
derived from the kidney of the fetus.
CD24 exosomes in the urine and amniotic fluid of mice
We wished to examine whether or not CD24 was an essential
component for vesicle formation. The human CD24 ortholog
in the mouse is heat-stable antigen (HSA/mouse CD24).12
We compared CD24þ /þ mice and CD24/ mice for
vesicle release into the urine. Urinary vesicles were collected
and analyzed by Western blot. As shown in Figure 7a, in
CD24þ /þ animals, exosomes were present in urine
containing CD24 and CD9, whereas in CD24/ animals
the CD24 signal was missing. Given the identical band
intensity of CD9 (Figure 7a) and the identical protein content
of exosomes (data not shown), we concluded that CD24 was
not essential for the process of exosome secretion.
We also investigated whether CD24-positive exosomes
were present in mouse amniotic fluid. As shown in Figure 7b
and similar to the results in humans, CD24-positive
exosomes were clearly detected in amniotic fluid of
CD24þ /þ mice but were absent in CD24/ mice. To
unequivocally prove that the exosomes were derived from the
fetus and not from the mother, we crossed CD24/ female
mice with wild-type male. This will give CD24þ / offspring
in a CD24/ mother. As shown in Figure 7b, the amniotic
fluid contained CD24-positive exosomes, suggesting their
origin from the fetus.
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Figure 6 | Sucrose gradient analysis of exosomes from amniotic fluid. (a) Density profile of an expanded sucrose gradient used
for the analysis of human amniotic fluid. Note the expansion of exosomal fractions compared to the gradient shown in Figure 2b.
(b) Exosomes isolated from the amniotic fluid of women undergoing amniocentesis were analyzed for the indicated marker proteins by
Western blot analysis.
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Figure 7 | CD24-containing exosomes in the urine and amniotic
fluid of mice. (a) Urine from C57B6 mice (CD24þ /þ ) and CD24/
mice were analyzed for CD24 and CD9 by Western blot analysis.
Note that the CD9 signals are similar in both CD24þ /þ and
CD24/ samples. (b) Amniotic fluid from pregnant CD24þ /þ ,
CD24/, or CD24/ female mice mated with CD24þ /þ
males (CD24þ /) was analyzed for CD24 and CD9 by Western
blot analysis.
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DISCUSSION
Membrane vesicles in the form of exosomes are released from
normal and cancer cells. In this study we have analyzed
vesicles present in human urine containing the GPI-anchored
protein CD24. We find that (i) CD24 vesicles are exosomes
and are most likely derived from the kidney; (ii) CD24
exosomes are present in the urine of newborn and in the
amniotic fluid of pregnant women and these vesicles are
derived from the kidney of the infant; (iii) CD24 exosomes
are also found in the urine and amniotic fluid of mice; (iv) in
CD24/ mice the secretion of vesicles into the urine is not
affected suggesting that CD24 is not essential in the vesicle-
release process. Our results suggest that exosomal secretion
into the urine and amniotic fluid is a biological process that
is conserved over species barriers and could play a role in
embryogenesis as well as in later life.
Clinical proteomics are extensively used to explore urinary
biomarkers.18 A surprisingly high abundance of membrane-
derived proteins was noticed in a recent study on total
urinary proteins.19 This publication did not address the fact
that urine contains both soluble proteins and urinary
exosomes that contain plasma membrane proteins derived
from the kidney and the urinary tract. Pisitkun et al.8
analyzed urinary exosomes using immunoelectron micro-
scopy and proteomic analysis. They noticed that released
exosomes were small (o100 nm) with variable size and were
oriented ‘cytoplasmic-side inward’. The authors also identi-
fied by liquid chromatography-tandem mass spectrometry
295 proteins including proteins known to be involved in
endosomal trafficking and exosome formation. In addition,
there were cytoskeletal and motor proteins, many integral
membrane proteins as well as eight GPI-anchored proteins.8
The cytosolic proteins identified were presumably trapped in
the lumina of forming exosomes. In our study the density
and orientation of urinary exosomes were similar to that
reported by Pisitkun et al.8 For unknown reasons the study
by Pisitkun et al.8 did not identify CD24 as a component of
urinary exosomes. This may be due to the unique feature of
human CD24 being a highly glycosylated mucin with a
protein core of only 31 amino acids. These characteristics
may have hampered the detection by proteomic analysis.
Nevertheless, the recruitment of CD24 from the plasma
membrane into exosomes is not surprising as GPI-anchored
proteins are known to be recruited into exosomes.15
Although the proteomic analysis of urinary exosomes can
provide important information about the pathophysiology of
the kidney, the biological relevance of the exosome secretion
process remains unaddressed. Using CD24 as a marker, we
found that the presence of exosomes in the urine of adults is a
constant feature with very little variation between individuals
and during the course of the day. Importantly, we found that
exosomes are present in the urine of newborns and can be
detected in the amniotic fluid of pregnant women under-
going amniocentesis, that is, as early as 14–18 weeks after
gestation. We used a separation technique on the basis of
buoyant density to further dissect the exosomes present in
amniotic fluid. We observed a fraction of exosomes that were
lighter in density and contained the kidney marker
aquaporin-2, CD24, and annexin-I. These exosomes were
most likely derived from the fetus. A second fraction of
exosomes contained annexin-I and HSP70 but not CD24. It
is possible that this subfraction originated from the mother.
The fetal origin of CD24 exosomes was confirmed by genetic
experiments in CD24 knockout mice. The presence of fetal
exosomes in the amniotic fluid is perhaps not so surprising in
the light of the know role of the fetal kidney in the
production of amniotic fluid. Nevertheless, these observa-
tions raise questions about the biological function of urinary
exosomes.
One possibility is that exosome secretion from the kidney
is important for the detoxification of the organism. Indeed,
recent data in tumors have shown that exosomes or
microvesicles with similar characteristics may cargo lipid-
solving drugs from tumors. An enhanced exosomal export of
cisplatin and abnormal lysosomal trafficking of the cisplatin
transporter was observed in drug-resistant human ovarian
carcinoma cells.20 Experiments with doxorubicin and other
small molecules confirmed drug accumulation and expulsion
in shed vesicles.21 Moreover, there was an accumulation of
drugs in membrane domains from which vesicles origi-
nated.21 It was proposed that by virtue of their hydrophobic
character, these molecules can be shuttled to the plasma
membrane via vesicle-mediated traffic, for final elimination
in complex with shed vesicles.21 If this was the case also in an
organism, then exosomes could cargo lipophilic substances
via the blood stream that are meant for secretion via the
urine, such as steroids or other substances that are not water-
soluble. In fact, exosomes are present in blood plasma8 and
this has been confirmed in our own studies (C Rupp,
unpublished data).
Exosomes were also implicated in the regulation of
immune responses.5,22 A role for exosomes in the modulation
of T-cell signaling during pregnancy has been suggested.23
Exosomes obtained from the serum of pregnant women
could suppress the expression of important T-cell signaling
components including CD3-z and JAK3. This suppression
was correlated with exosome-associated Fas ligand, and a
striking difference was noted between women delivering
at term and those delivering pre-term.23 This study assumed
a maternal origin of the isolated exosomes and did not take a
possible fetal origin into account. Our study shows for the
first time that fetal exosomes are present in amniotic fluid. As
fetal cells are known to occur in the maternal blood
circulation, we cannot rule out the possibility that exosomes
from the fetus are present in the bloodstream of the mother.
Interestingly, exosomes display both immunostimulatory but
also immunosuppressive properties.22 For example, exosomes
produced by mouse dendritic cells pulsed with tumor peptide
are able to mediate the rejection of established tumors.24
These antitumor effects were antigen-specific and were
associated with the activity of T cells. Direct stimulation of
T cells by membrane vesicles from antigen-presenting cells
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has also been reported.25 Conversely, it has been suggested
that intestinal epithelial cells, T-cell tumors, and melanoma
cells can secrete exosomes capable of inducing antigen-
specific tolerance and Fas ligand-mediated T-cell apoptosis.26
Exosomes derived from tumor cells were also shown to
inhibit the cytolytic activity of natural killer (NK) cells by
reducing the levels of perforin in NK cells, a molecule that is
essential for target cell lysis.27 It is of interest to note that a
major fraction of cells in the amniotic fluid are decidual NK
cells that play an important role in trophoblast invasion and
the vascularization of the uterus.28 In contrast to peripheral
NK cells, decidual NK cells secrete a variety of cytokines but
are non-cytolytic.28 It is tempting to speculate that exosomes
may be involved in the inhibition of cytolytic activity of
decidual NK cells similar to the tumor situation. Finally, a
recent study has shown that exosomes can transport mRNA
and microRNAs and represent a novel mechanism of genetic
exchange between cell.29 For urinary exosomes future work
will be required to analyze closely a possible role for nephron
function. Also the immunological properties of fetal
exosomes at the maternal–fetal interphase need to be
investigated further.
In summary, our results describe the phenomenon of
exosome secretion in the human renal system. The data
provided on mouse CD24 exosomes in the urine and
amniotic fluid highlight that the secretion process is
conserved over species borders. This similarity now allows
experimental studies in animals to further unravel the
biological role of exosome secretion.
MATERIALS AND METHODS
Chemicals and antibodies
Antibodies to human CD24 (SWA11) and CD9 (TS9) were
described.7,14 The mAbs to HSP70, annexin-I, and mouse CD9
were from BD-Transduction (Heidelberg, Germany). The antibodies
to aquaporin-2 and calbindin 28K were from Sigma (Taufkirchen,
Germany), and the antibody to WT1 (sc-846) was obtained from
Santa Cruz (Heidelberg, Germany). The Tamm–Horsfall antibody
was from Biotrend (Ko¨ln, Germany). The antibodies to mouse
CD24 are described before.30
Cell culture and animals
Human conditionally immortalized podocytes (HPC) were isolated
and cultivated as described previously.31 Cells were grown in flasks
either at the permissive temperature of 321C (in 5% CO2) to
promote cell propagation as a cobblestone phenotype (undiffer-
entiated) or at the nonpermissive temperature of 371C (in 5% CO2)
to inactivate the SV40 T antigen and to allow the cells to
differentiate. Before stimulation, cells were incubated for 16 h in
RPMI-1640 medium, supplemented with 0.1 mg/ml of fatty acid-
free bovine serum albumin. HK-2 human proximal tubular
epithelial cells were obtained from American Type Culture
Collection (ATCC, Manassas, VA, USA). Human mesangial cells
were kindly provided by Professor Dr Radeke (Department of
Pharmacology, University of Frankfurt). Briefly cells were grown in
RPMI-1640 medium supplemented with nonessential amino acids
(1 ml/dl), L-glutamine (2 mM), sodium pyruvate (1 mM), transferrin
(5 mg/ml), insulin (125 U/ml), and fetal calf serum (10%). Cells
were grown at 371C in 5% CO2. For passaging, human mesangial
cell were detached by trypsin-EDTA and split into 1:3. CD24/
mice (C57BL6) were originally obtained from Dr Peter Nielsen
(Max-Planck Institute for Immunobiology, Freiburg, Germany) and
maintained at the animal house of the DKFZ. Normal age-matched
C57BL6 mice served as control.
Isolation of vesicles from urine
Urinary samples were obtained from healthy volunteers (male and
female age range 22–57 years) and were collected during the course
of a working day. Urine samples (50 ml from adults; 5 ml from
newborn) were centrifuged for 10 min at 300 g and 20 min at
10 000 g to remove cellular debris. Membrane vesicles were collected
by centrifugation at 100 000 g for 2 or 18 h at 41C using a Beckman
SW 40 rotor. Vesicles were directly dissolved in sodium dodecyl
sulfate (SDS) sample buffer in relation to the original volume or
processed further for gradient centrifugation (see below). Mouse
urine was collected in metabolic cages. Drinking water contained
16% sucrose and urine (approximately 5 ml/16 h) was collected on
ice. Mouse urine was processed as described above.
Isolation of vesicles from amniotic fluid
Human amniotic fluid (n¼ 4) was collected for routine amnio-
centesis and analyzed after removal of cells. Membrane vesicles were
obtained after differential centrifugation as described above.
Amniotic fluids from mice (approximately 100–500ml) were
collected on day 18 of gestation and were spun in an Eppendorf
centrifuge at maximum speed for 20 min. The cell debris-free
supernatant was diluted into 4 ml of phosphate-buffered saline, and
vesicles were pelleted by overnight centrifugation using a Beckman
SW60 rotor at 120 000 g. The vesicle pellet was taken up in SDS
sample buffer.
Sucrose density gradient fractionation
Vesicles isolated from ascites were loaded onto the top of a step
gradient comprising layers of 2, 1.3, 1.16, 0.8, 0.5, and 0.25 M sucrose
as described.18 The gradients were centrifuged for 2.5 h at 100 000 g
in a Beckman SW40 rotor. Twelve 1 ml fractions were collected from
the top of the gradient and precipitated by chloroform/methanol or
acetone as described.18 A modified sucrose gradient was designed to
allow a more refined analysis of exosomes according to differences in
the density.
FACS analysis
FACS analysis of isolated vesicles was carried out after adsorbing of
isolated vesicles to 4 nm (Surfactant-free) aldehyde-sulfate latex
beads (Interfacial Dynamics Corp, Portland, OR, USA) as
described.32 The staining of beads or cultivated cells with mAbs
and phycoerythrin-conjugated secondary antibodies has been
described.14,18 Stained beads or cells were analyzed with a FACScan
using Cellquest software (Becton Dickinson, Heidelberg, Germany).
Immunohistochemistry
This was described previously.33 Briefly, paraffin tissue sections were
deparaffinized and antigens were retrieved for 20 min by incubating
the tissue sections in 0.01 M sodium citrate buffer, pH 6.0, in a
microwave (500 W). The intrinsic peroxidase activity was abolished
by pretreatment in 3% H2O2 in methanol for 30 min at RT. After
blocking, the sections were incubated with an Avidin/Biotin
Blocking kit (Linaris, Wertheim, Germany) following the manu-
facturer’s protocol. The sections were incubated overnight with
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CD24 antibody (SWA11 hybridoma supernatant diluted 1:5 in
blocking reagent). After washing the slides, the Universal Quick kit
(Linaris) was used for staining. As substrate, the AEC Substrate kit
from BioGenex (San Ramon, CA, USA) was used to detect immune
complexes. To counterstain the sections, slides were incubated with
hematoxylin (Roth, Karlsruhe, Germany). For double-staining
CD24 with WT1, a specific podocyte marker, sections were not
counterstained with hematoxylin. WT1 antibody was diluted 1:250
in blocking reagent (1% bovine serum albumin in phosphate-
buffered saline) and incubated overnight. After washing the sections,
the alkaline phosphatase-conjugated goat-anti rabbit antibody
(1:250 diluted in blocking reagent) was added for 1 h at 371C.
Endogenous alkaline phosphatase was blocked with levamisole
(Sigma) before adding the substrate. The immune complex was
detected adding the Sigma fastTM BCIP/NBT (Sigma) substrate tablet
until a blue color developed.
Biochemical analysis
SDS-polyacrylamide gel electrophoresis under reducing conditions
and transfer of proteins to an immobilon membrane using semi-dry
blotting has been described.14,18 After blocking with 5% skim milk
in Tris-buffered saline, the blots were developed with the respective
primary antibody followed by peroxidase-conjugated secondary
antibody and enhanced chemiluminescence detection.
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